Danish startup Algiecel has strengthened its senior leadership team as it prepares to scale up its marine bioactives platform.
Mette Ingeman Pedersen has been appointed as chief financial officer while Tove Feld is chair of its board of directors.
The appointments strengthen a female-led leadership team headed by CEO Susanne Palsten Buchardt (pictured, centre) and support Algiecel’s next phase of growth, building the financial, operational and governance capabilities needed to scale its controlled marine bioactives platform for personal care and other markets.
Pedersen (pictured, left) joins Algiecel after more than 20 years in senior finance, advisory and commercial roles across the Nordic region, with a focus on helping science-based and purpose-driven companies turn innovation into scalable business models.
“My focus will be on helping Algiecel build the structure, investor confidence and financial resilience needed for long-term growth,” she said.
“Algiecel is entering a decisive stage, where strong financial discipline must support ambitious commercial execution.
“The company has developed a platform with the potential to make high-performing microalgae ingredients more reliable, scalable and commercially accessible.”
At the same time, Tove (pictured, right) will chair Algiecel’s board of directors with 35 years of experience in energy, infrastructure, renewables and strategic transformation, including more than 15 years of board experience across private and listed companies.
Algiecel’s compact, modular bioreactors cultivate Nannochloropsis oceanica microalgae using artificial light, water and captured CO₂.
The model is designed to provide predictable supply, consistent product quality and lower-risk, flexible scaling, helping customers reduce exposure to marine ingredient supply volatility.
Algiecel raised DKK 60m ($9m) in 2024 to support the continued development and scale-up of its technology.
“Scaling Algiecel requires more than promising technology,” said CEO Buchardt.
“It requires operational discipline, financial rigour, industrial experience and a leadership team capable of turning innovation into reliable commercial supply,” she added.
“Mette and Tove bring exactly that. Their appointments strengthen our ability to execute as we build Algiecel into a trusted supplier of effective microalgae ingredients delivered at scale.”
